Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 After Another Legal Setback on BRCA Testing, Myriad Considers Other Options

After Another Legal Setback on BRCA Testing, Myriad Considers Other Options

Myriad Genetics is continuing to legally duke it out with some of its competitors in breast and ovarian cancer genetic testing, but it is appearing increasingly likely that it will have to accept that the space will be crowded for the foreseeable future. A federal appeals court in Utah ruled in December that three patents […]

Myriad Genetics is continuing to legally duke it out with some of its competitors in breast and ovarian cancer genetic testing, but it is appearing increasingly likely that it will have to accept that the space will be crowded for the foreseeable future. A federal appeals court in Utah ruled in December that three patents…

This content is for Paid Members only.
Login Register